PEDERZOLI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 2.029
EU - Europa 1.778
AS - Asia 1.557
SA - Sud America 389
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 38
OC - Oceania 2
Totale 5.899
Nazione #
US - Stati Uniti d'America 1.923
RU - Federazione Russa 969
SG - Singapore 449
CN - Cina 432
HK - Hong Kong 330
BR - Brasile 321
IT - Italia 262
SE - Svezia 175
VN - Vietnam 151
DE - Germania 102
FR - Francia 70
CA - Canada 62
GB - Regno Unito 56
FI - Finlandia 47
BD - Bangladesh 42
IN - India 36
AR - Argentina 26
MX - Messico 23
NL - Olanda 23
PL - Polonia 23
JP - Giappone 18
ID - Indonesia 17
ZA - Sudafrica 15
TR - Turchia 13
EC - Ecuador 11
ES - Italia 10
IE - Irlanda 10
EG - Egitto 9
IQ - Iraq 9
PY - Paraguay 9
AT - Austria 8
CO - Colombia 8
IR - Iran 8
MY - Malesia 8
JM - Giamaica 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
MA - Marocco 5
PK - Pakistan 5
UA - Ucraina 5
UZ - Uzbekistan 5
LT - Lituania 4
NP - Nepal 4
TN - Tunisia 4
EU - Europa 3
GT - Guatemala 3
JO - Giordania 3
KE - Kenya 3
NI - Nicaragua 3
SA - Arabia Saudita 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AU - Australia 2
BE - Belgio 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HN - Honduras 2
IL - Israele 2
KR - Corea 2
KW - Kuwait 2
PH - Filippine 2
UY - Uruguay 2
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
VC - Saint Vincent e Grenadine 1
Totale 5.799
Città #
Hong Kong 327
Ashburn 264
Singapore 227
Moscow 201
Dallas 173
San Jose 167
New York 94
Shanghai 74
Milan 73
Council Bluffs 65
Beijing 63
Los Angeles 59
Ho Chi Minh City 56
Hefei 52
Santa Clara 43
Lauterbourg 40
Lawrence 37
Princeton 37
Phoenix 33
Rome 33
Munich 32
Hanoi 31
Boardman 28
São Paulo 26
Montreal 22
Orem 22
Turku 21
Atlanta 20
Denver 20
Helsinki 18
Miano 17
Warsaw 17
Frankfurt am Main 16
Houston 13
San Francisco 13
Tokyo 13
North Bergen 12
Nuremberg 12
Toronto 12
Chennai 11
Guangzhou 11
Mumbai 11
Amsterdam 10
Brooklyn 10
Chicago 10
Dublin 10
Johannesburg 10
London 10
Rio de Janeiro 10
Da Nang 9
Haiphong 9
Poplar 9
Mexico City 8
Salvador 8
Stockholm 8
Turin 8
Lappeenranta 7
Naples 7
Seattle 7
Boston 6
Brasília 6
Cairo 6
Cesano Boscone 6
Charlotte 6
Columbus 6
Hanover 6
Kingston 6
Querétaro 6
Ankara 5
Buffalo 5
Caxias do Sul 5
Guayaquil 5
Indpls 5
Manchester 5
Memphis 5
The Dalles 5
Verona 5
Biên Hòa 4
Can Tho 4
Caracas 4
Chengdu 4
City of London 4
Concord 4
Curitiba 4
Fortaleza 4
Hangzhou 4
Jacksonville 4
Medellín 4
New Delhi 4
Porto Alegre 4
Pune 4
Quito 4
Raleigh 4
Segrate 4
São José do Rio Preto 4
Tampa 4
Tashkent 4
Vienna 4
Abu Dhabi 3
Barnet 3
Totale 2.855
Nome #
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 243
Heavy cigarette smoking and alcohol consumption are associated with impaired sperm parameters in primary infertile men 207
Microbiome and bladder cancer 180
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 176
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 175
Testicular volume in infertile versus fertile white-European men: a case-control investigation in the real-life setting 163
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 156
A global approach to improving penile cancer care 149
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 149
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer 143
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age 141
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 140
Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer 135
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 133
A risk calculator predicting recurrence in lymph node metastatic penile cancer 129
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 127
Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods 126
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 126
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 122
Causal contributors to tissue stiffness and clinical relevance in urology 122
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 121
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 121
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 114
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 114
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 114
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 113
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 112
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 110
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 105
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 101
Topographic modification of the extracellular matrix precedes the onset of bladder cancer 99
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 93
Risk of health status worsening in primary infertile men: A prospective 10-year follow-up study 90
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma 89
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 84
Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy 79
Neoadjuvant chemotherapy for lymph node-positive penile cancer: Current evidence and knowledge 78
Revolutionizing care for rare genitourinary tumours 78
Re: High blood pressure is a highly prevalent but unrecognised condition in primary infertile men: Results of a cross-sectional study 78
Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence 77
Targetable gene fusions and aberrations in genitourinary oncology 76
Semen infections in men with primary infertility in the real-life setting 72
Regenerative and engineered options for urethroplasty 72
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma 70
Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm? 67
The new era of precision urobiome: RE: “Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study” by Chipollini et al 67
Whole exome data prioritization unveils the hidden weight of Mendelian causes of male infertility. A report from the first Italian cohort 63
The Gut and Urinary Microbiota: A Rising Biomarker in Genitourinary Malignancies 63
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies 63
Re: Undiagnosed Prediabetes is Highly Prevalent in Primary Infertile Men-Results from a Cross-Sectional Study 63
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 61
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 58
Testis Molecular Pathways in CAIS Unveil Testosterone/Estradiol on Germ Cell Tumor Risk in Non-Obstructive Azoospermia 23
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review 11
Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should We Revisit the Goals of Care? 10
HER2 and urothelial carcinoma: current understanding and future directions 9
Author Correction: A global approach to improving penile cancer care (Nature Reviews Urology, (2022), 19, 4, (231-239), 10.1038/s41585-021-00557-y) 8
Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference? 8
Pathologic Features of Response to Neoadjuvant Therapies in Muscle-Invasive Bladder Cancer: More than Meets the Eye 7
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 6
The Pros and Cons of 'Machination of Medicine' in Genitourinary Oncology Practice 5
null 1
null 1
null 1
null 1
null 1
Totale 5.899
Categoria #
all - tutte 27.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202289 0 0 0 20 3 4 15 9 5 7 3 23
2022/2023313 91 70 26 15 5 35 11 25 15 5 5 10
2023/2024312 11 26 33 31 29 72 10 40 1 4 8 47
2024/20251.131 99 41 16 40 61 77 183 268 120 82 57 87
2025/20263.122 190 234 223 410 282 99 221 213 872 143 77 158
2026/2027892 168 157 154 413 0 0 0 0 0 0 0 0
Totale 5.899